IBS Prime

Viewing Options

Webcast

Topic Information

Goal Statement

This activity has been designed to encourage the application of the latest advances in evidence-based medicine to achieve improved outcomes for the patients affected by IBS.

Target Audience

The enduring material will target primary care providers (PCPs) and allied health professionals.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Apply evidence-based diagnostic criteria to evaluate patients presenting with symptoms of suggestive of IBS.

Identify patients with alarm symptoms who require further diagnostic investigation.

Incorporate evidence-based treatment plans for patients with IBS-C and CIC effectively into practice.

Incorporate evidence-based treatment plans for patients with IBS-D effectively into practice.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Gi Health Foundation. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Purdue University College of Pharmacy designates this live meeting for a maximum of
1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

Purdue University Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This program has been approved for 1.0 contact hours. Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-17-086-H01-P, 1.0 contact hours (1.0 CEU).

Disclosure Statement

All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

BROOKS CASH, MD
Consultant: Salix, Allergan, QOL Medical, IM HealthScience, Synergy, Ironwood
Advisory Board Membership: Salix, Allergan, Ironwood
Speaker Bureau: Salix, Allergan, Synergy
Editorial Board Involvement: American Journal of Gastroenterology

PHILIP SCHOENFELD, MD
Advisory Board: Ironwood, Allergan, Salix, Synergy, Daiichi-Sankyo
Consultant: Ironwood, Allergan, Salix
Other: MD-Evidence

Release Date: November 20th, 2017
Expiration Date: November 20th, 2018

This activity is supported by educational grants from Allergan, Inc., Commonwealth Diagnostics International, Inc., Ironwood Pharmaceuticals, Inc., and Salix Pharmaceuticals.

Provided by:

Accredited by

© Copyright 2013-2017 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.